Amantadine Augmentation Therapy for Obsessive Compulsive Patients Resistant to SSRIs—An Open-Label Study

Title
Amantadine Augmentation Therapy for Obsessive Compulsive Patients Resistant to SSRIs—An Open-Label Study
Authors
Keywords
-
Journal
CLINICAL NEUROPHARMACOLOGY
Volume 37, Issue 3, Pages 79-81
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-05-13
DOI
10.1097/wnf.0000000000000029

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started